60세 이상 노인 인구에서 인지기능과 우울증, 자살사고, 혈청지질농도와의 연관성

키워드

참고문헌 (45)

1. Razay G, "The metabolic syndrome and alzheimer disease", Arch Neurol, 64, pp.93~96 (2007)
2. Arvanitakis Z, "Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function", Arch Neurol, 61, pp.661~666 (2004)
3. Heron DS, "Lipid fluidity markedly modulates the binding of serotonin to mouse brain membranes", roc Natl Acad Sci U S A, 77, pp.7463~7467 (1980)
4. Ballmaier M, "Anterior cingulate, gyrus rectus, and orbitofrontal abnormalities in elderly depressed patients: an MRI-based parcellation of the prefrontal cortex", Am J Psychiatry, 151, pp.99~108 (2004)
5. Eckert GP, "Cholesterol modulates the membrane-disordering effects of beta-amyloid peptides in the hippocampus: specific changes in Alzheimer’s disease", Dement Geriatr Cogn Disord, 11, pp.181~186 (2000)
6. Kivipelto M, "Midlife vascular ria¨ sk factors and late-life mild cognitive impairment: A poa¨pulation-based study", Neurology, 56, pp.1683~1689 (2001)
7. Romas SN, "APOE genotype, plasma lipids, lipoproteins, and AD in community elderly", Neurology, 53, pp.517~521 (1999)
8. Partonen T, "Association of low serum total cholesterol with major depression and suicide", British Journal of Psychiatry, 175, pp.259~262 (1999)
9. Colin A, "Lipids, depression and suicide", Encephale, 29, pp.49~58 (2003)
10. Tanskanen A, "High serum cholesterol and risk of suicide", Am J Psychiatry, 157, pp.648~650 (2000)
11. McCallum J, "Low serum cholesterol is not associated with depression in the elderly: data from an Australian community study", Australian and New Zealand Journal of Medicine, 24, pp.561~564 (1994)
12. Reuben DB, "The predictive value of combined hypoalbuminemia and hypocholesterolemia in high functioning community-dwelling older persons: MacArthur Studies of Successful Aging", J Am Geriatr Soc, 47, pp.402~406 (1999)
13. 김정은, "60세 이상 노인 인구에서 우울증과 자살의 위험인자", 생물치료정신의학, 16(1), pp.46~53 (2010), 대한생물치료정신의학회
14. Jung IK, "A reliabilty and validity study of geriatric depression scale", J Korean Neuropsychiatr Assoc, 36, pp.103~112 (1997)
15. Beck AT, "Assessment of suicidal intention: the Scale for Suicide Ideation", J Consult Clin Psychol, 47, pp.343~352 (1979)
16. Shin MS, "A study of sticidal ideation among high school students: the stuctural relation among depression, hopelessness, and suicidal ideation", Korean J Clin Psychol, 9, pp.1~19 (1990)
17. Koenig HG, "Selfrated depression scales and screening for major depression in the older hospitalized patient with medical illness", J Am Geriatr Soc, 36, pp.699~706 (1988)
18. McGivney SA, "Validating the GDS depression screen in the nursing home", J Am Geriatr Soc, 42, pp.490~492 (1994)
19. Hachinski VC, "Cerebral blood flow in dementia", Arch Neurol, 32, pp.632~637 (1975)
20. Hughes CP, "A new clinical scale for the staging of dementia", Br J Psychiatry, 140, pp.566~572 (1982)
21. Gabryelewicz T, "The rate of conversion of mild cognitive impairment to dementia: predictive role of depression", Int J Geriatr Psychiatry, 22, pp.563~567 (2007)
22. Barnes DE, "Depressive symptoms, vascular disease, and mild cognitive impairment: findings from the Cardiovascular Health Study", Arch Gen Psychiatry, 63, pp.273~279 (2006)
23. Reuben DB, "The predictive value of combined hypoalbuminemia and hypocholestrolemia in high functioning community-dwelling older persons: MacArthur Studies of Successful Aging", J Am Geriatr Soc, 47, pp.402~406 (1999)
24. Kivipelto M, "Midlife vascular risk factors and late-life mild cognitive impairment: A population-based study", Neurology, 56, pp.1683~1689 (2001)
25. Yaffe K, "Serum lipoprotein levels, statin use, and cognitive function in older women", Arch Neurol, 59, pp.378~384 (2002)
26. Notkola IL, "Serum total cholesterol, apolipoprotein E epsilon 4 allele, and Alzheimer’s disease", Neuroepidemiology, 17, pp.14~20 (1998)
27. Evans RM, "Serum cholesterol, APOE genotype, and the risk of Alzheimer’s disease: a population-based study of African Americans", Neurology, 54, pp.240~242 (2000)
28. Merched A, "Decreased high-density lipoprotein cholesterol and serum apolipoprotein AI concentrations are highly correlated with the severity of Alzheimer’s disease", Neurobiol Aging, 21, pp.27~30 (2000)
29. Ward MA, "Low HDL Cholesterol is Associated with Lower Gray Matter Volume in Cognitively Healthy Adults", Front Aging Neurosci, 2, pp.29~ (2010)
30. Singh-Manoux A, "Low HDL cholesterol is a risk factor for deficit and decline in memory in midlife: the Whitehall II study", Arterioscler Thromb Vasc Biol, 28, pp.1418~1420 (2008)
31. Michikawa M, "Cholesterol paradox: is high total or low HDL cholesterol level a risk for Alzheimer’s disease?", J Neurosci Res, 72, pp.141~146 (2003)
32. Olesen OF, "High density lipoprotein inhibits assembly of amyloid beta-peptides into fibrils", Biochem Biophys Res Commun, 270, pp.62~66 (2000)
33. Reiss AB, "Cholesterol in neurologic disorders of the elderly: stroke and Alzheimer’s disease", Neurobiol Aging, 25, pp.977~989 (2004)
34. Cockerill GW, "Elevation of plasma highdensity lipoprotein concentration reduces interleukin-1-induced expression of E-selectin in an in vivo model of acute inflammation", Circulation, 103, pp.108~112 (2001)
35. Paterno` R, "Reconstituted high-density lipoprotein exhibits neuroprotection in two rat models of stroke", Cerebrovasc Dis, 17, pp.204~211 (2004)
36. Reuben DB, "The predictive value of combined hypoalbuminemia and hypocholestrolemia in high functioning community-dwelling older persons: MacArthur Studies of Successfun Aging", J Am Geriatr Soc, 47, pp.402~406 (1999)
37. Partonen T, "Association of low serum total cholesterol with major depression and suicide", Br J of Psychiatry, 175, pp.259~262 (1999)
38. Colin A, "Lipids, depression and suicide", Encephale, 29, pp.49~58 (2003)
39. Yaffe K, "Serum lipoprotein levels, statin use, and cognitive function in older women", Arch Neurol, 59, pp.378~384 (2002)
40. Bove M, "Psychosocial factors and metabolic parameters: Is there any association in elderly people? The Massa Lombarda Project", Aging Ment Health, 9, pp.1~6 (2010)
41. Song F, "Plasma biomarkers for mild cognitive impairment and Alzheimer’s disease", Brain Res Rev, 61, pp.69~80 (2009)
42. Cramer C, "Use of statin and incidence of dementia and cognitive impairment without dementia in a cohort study", Neurology, 71, pp.344~350 (2008)
43. Sparks DL, "Reduced risk of incident AD with elective statin use in a clinical trial cohort", Curr Alzheimer Res, 5, pp.416~421 (2008)
44. Haag MD, "Statins are associated with a reduced risk of Alzheimer’s disease regardless of lipophilicity. The Rotterdam Study", J Neurol Neurosurg Psychiatry, 80, pp.13~17 (2009)
45. Sparks DL, "Cholesterol and cognitive performance in normal controls and the influence of elective statin use after conversion to mild cognitive impairment: results in a clinical trial cohort", Neurodegener Dis, 7, pp.183~186 (2010)

관련 논문AI추천